FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 3213034 · Received July 9, 2013

Report

Report Number
2124215-2013-09463
Event Type
Malfunction
Date Received
July 9, 2013
Date of Event
June 1, 2013
Report Date
June 2, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE REMOTE PATIENT MONITORING SYSTEM RECORDED AN ALERT FOR A HIGH PACE IMPEDANCE MEASUREMENT ON THIS PATIENT'S RIGHT VENTRICULAR (RV) LEAD. AN ACUTE CHANGE GREATER THAN 500 OHMS WAS OBSERVED. NO FURTHER FOLLOW-UP HAS BEEN PERFORMED AND THE PATIENT'S CLINIC WILL CONTINUE TO MONITOR THEIR SYSTEM. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THIS PRODUCT REMAINS IN SERVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
313497 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 73 YR 5072| 7271| 6942| E110